Business Of Biotech
Ben Comer
Key Metrics
About the Show
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
Partnership & Audience Signals
Ads or sponsor reads already detected
20 of recent episodes transcribed
296 episodes — long track record
Production & Distribution
Feed Capabilities Podcasting 2.0
Advanced RSS tags in this feed — signals for transcripts, dynamic ad insertion, and analytics support.
Recent Episodes
Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Thomas von Erlach, Ph.D., Cofounder and CEO at Vivtex, a company spun out…
An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we speak with Monika Sumra, Ph.D., about how leadership, culture, and performance emerge from…
Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jared Bauer, Cofounder and CEO at Seek Labs, talks about his adventures in company…
Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite Pharma,…
BoB@JPM: Brian Hilberdink, Boehringer Ingelheim
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show…
BoB@JPM: Ron Cooper, enGene
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech -- on location at the J.P. Morgan Healthcare Conference -- we're speaking with Ron Cooper, CEO…
BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics
We love to hear from our listeners. Send us a message. The Business of Biotech was back in San Francisco for the J.P. Morgan Healthcare Conference (January 12 - 15) and this week we sit down with…
A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Kenneth Galbraith, CEO and Board Chair at Zymeworks, a biotech developing…
Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
We love to hear from our listeners. Send us a message. This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk…
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy…
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about…
Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic research to industry…
Engineering B Cells With Immusoft's Sean Ainsworth
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Sean Ainsworth, CEO and Chairman at Immusoft, talks about transitioning from the research…
Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dan Schmitt, President and CEO at Actuate Therapeutics, talks about building a company around…
Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.
We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of…
Biotech Funding And IPO Temperature Check With Create Medicine's Allan Shaw
We love to hear from our listeners. Send us a message. Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with a…
Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals, talks about building relationships in investment…
Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged…
BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals
We love to hear from our listeners. Send us a message. On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst…
BoB In South Florida: Anthony Japour, M.D., iTolerance
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals' Miami…
Market Reports
Benchmark this show against its category and language peers.
Similar Podcasts
Comparable shows in the same category and language — useful for prospecting and competitive sets.
Business Of Biotech
Ben Comer
311 episodes
Yoga Therapy Hour with Amy Wheeler
Amy Wheeler
247 episodes
Holdback Rack Podcast
Jessica Hare
242 episodes
The Business of Blueberries
U.S. Highbush Blueberry Council
200 episodes
THE EMBC NETWORK Featuring: ihealthradio and Worldwide Podcasts
Hurricane H
838 episodes
The Legal Field: Legal Perspectives in the Agriculture Industry
Amanda Carl
16 episodes
Profile compiled from public podcast metadata · Last refreshed June 15, 2026